Clinical Trials · NCT04943159
Afamelanotide in Patients Suffering With Acne Vulgaris
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Clinuvel Pharmaceuticals Limited
- Enrollment
- 3
- Start date
- Aug 2010
- Locations
- See registry
- Primary endpoint
- The Change in Number of Facial Inflammatory Acne-related Lesions.